Released Mar 16, 2012, during market hours
10-Q filed Mar 16, 2012, 45 days after period end · 0001354488-12-001197
Q1 2012 · 10-Q
Revenue—
Net Income$1.15M$1.15M +221.8% vs Q1 2011+39.1% vs Q4 2011
EPS Diluted$0.05$0.05 +212.5% vs Q1 2011no prior Q4 2011 on file
Gross Profit$2,246,645+91.0%
Operating Income$1,361,945+163.2%
Operating Cash Flow-$106,041N/M
Free Cash Flowderived-$113,002N/M
What the release said
No earnings release is on file for this quarter. Its figures came with the 10-Q.
Same quarter
| Metric | Q1 2012 | Q1 2011 |
|---|---|---|
| Net Income | $1.15M | $356.26K |
| EPS Diluted | $0.05 | $0.02 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Pharma-Bio Serv, Inc. · CIK 1304161 · Engraved from SEC EDGAR